Researchers at the University of California, Davis have engineered dominant negative CD40L mutant polypeptides that inhibit CD40/CD40L-mediated signaling, offering therapeutic potential for inflammatory, immune disorders, and cancer with improved safety profiles.

Researchers at the University of California, Davis have developed a computer-implemented method to identify viral mutations that enhance transmission and predict their prevalence in populations over time.

Researchers at the University of California, Davis have developed technology that provides an advanced system for monitoring and supporting patient resuscitation and mechanical ventilation, enhancing clinical decision-making.

Researchers at the University of California, Davis have developed tactile feedback systems that enhance spatial and sensory resolution in sensor arrays through unique signal modulation techniques.

Researchers at the University of California, Davis have developed an approach to enhance autonomous vehicle path prediction through efficient information sharing and distributed learning among AI agents.

Researchers at the University of California, Davis have developed non-invasive fetal monitoring that enables accurate, continuous measurement of fetal arterial blood oxygen saturation and blood pH.

Researchers at the University of California, Davis have developed a technology that introduces a highly adaptable, lightweight robotic end effector designed for complex manipulation tasks in automation.

Researchers at the University of California, Davis have developed a Brain-Computer Interface (BCI) technology that enables individuals with paralysis to communicate and control devices through multimodal speech and gesture neural activity decoding.